Brief: Revvity Collaborates With Lilly To Expand Access To Ai Drug Discovery Models
09/01/2026 13:48
Jan 9 (Reuters) - Revvity Inc RVTY.N: REVVITY COLLABORATES WITH LILLY TO EXPAND ACCESS TO AI DRUG DISCOVERY MODELS REVVITY COLLABORATES WITH LILLY TO EXPAND ACCESS TO AI DRUG DISCOVERY MODELS REVVITY INC: COLLABORATION FUNDS PARTICIPATING BIOTECHS TO ACCESS LILLY PREDICTIVE MODELS THROUGH REVVITY SIGNALS XYNTHETICA OFFERING Source text: ID:nBw8rNmlRa Further company coverage: RVTY.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Revvity
See all newsBrief: Revvity Launches Signals Labgistics Solution To Connect And Orchestrate Scientific Workflows
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT